<div id="readability-page-1"><p>Ashton Thomas Securities LLC trimmed its position in  Centene Corporation (NYSE:CNC - Free Report) by 74.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 14,822 shares of the company's stock after selling 42,608 shares during the quarter. Ashton Thomas Securities LLC's holdings in Centene were worth $529,000 as of its most recent SEC filing.</p><ul><li>MarketBeat Week in Review – 07/07 - 07/11</li></ul><p>A number of other large investors have also recently bought and sold shares of CNC. Kera Capital Partners Inc. lifted its stake in  Centene by 179.0% during the 3rd quarter. Kera Capital Partners Inc. now owns 13,588 shares of the company's stock valued at $485,000 after acquiring an additional 8,717 shares during the period.  Concurrent Investment Advisors LLC purchased a new position in shares of  Centene during the third quarter worth $244,000.  Financial Network Wealth Advisors LLC lifted its position in  Centene by 54.9% during the third quarter. Financial Network Wealth Advisors LLC now owns 1,100 shares of the company's stock valued at $39,000 after purchasing an additional 390 shares during the period.  Bogart Wealth LLC grew its position in  Centene by 11,011.1% during the 3rd quarter. Bogart Wealth LLC now owns 1,000 shares of the company's stock worth $36,000 after purchasing an additional 991 shares during the period.  Finally, Quent Capital LLC purchased a new position in shares of  Centene during the 3rd quarter valued at about $45,000. Hedge funds and other institutional investors own  93.63% of the company's stock. </p><h2>Centene Price Performance</h2><p>Centene stock opened at $46.15 on Thursday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.08 and a current ratio of 1.08. The company's fifty day moving average price is $39.79 and its 200 day moving average price is $34.79. The stock has a market capitalization of $22.68 billion, a P/E ratio of -4.26, a P/E/G ratio of 1.04 and a beta of 0.48. Centene Corporation has a 1 year low of $25.08 and a 1 year high of $66.81. </p><ul><li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li></ul><p>Centene (NYSE:CNC - Get Free Report) last announced its earnings results on Wednesday, October 29th. The company reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.21) by $0.71. Centene had a negative net margin of 2.85% and a positive return on equity of 7.82%. The business had revenue of $49.69 billion for the quarter, compared to analyst estimates of $47.50 billion. During the same quarter last year, the business earned $1.62 earnings per share. The company's revenue for the quarter was up 18.2% compared to the same quarter last year.  As a group, equities research analysts anticipate that  Centene Corporation will post 6.86 earnings per share for the current fiscal year. </p><h2>Analyst Ratings Changes</h2><p>A number of analysts have recently commented on CNC shares. Morgan Stanley upped their target price on Centene from $28.00 to $38.00 and gave the stock an &#34;equal weight&#34; rating in a research note on Tuesday, October 14th. Jefferies Financial Group boosted their price target on Centene from $25.00 to $32.00 in a report on Monday, November 3rd. Oppenheimer  reaffirmed an &#34;outperform&#34; rating and set a $45.00 price objective on shares of Centene in a research note on Thursday, October 30th. Robert W. Baird boosted their target price on shares of Centene from $28.00 to $36.00 and gave the company a &#34;neutral&#34; rating in a research note on Thursday, December 11th. Finally, Truist Financial raised their price target on shares of Centene from $45.00 to $47.00 and gave the company a &#34;buy&#34; rating in a research report on Monday, January 5th. Three analysts have rated the stock with a Buy rating, fourteen have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company  has an average rating of &#34;Hold&#34; and an average target price of $40.38.</p><ul><li>Top Analyst-Rated Healthcare Stocks to Watch Now</li></ul><p><b>View Our Latest Stock Report on Centene</b></p><h2>Centene Profile</h2> (Free Report)<p>Centene Corporation <span>NYSE: CNC<span></span></span> is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children's Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.  </p><p>Centene's offerings extend beyond traditional insurance to include a range of specialty and support services.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Centene</li><li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li><li>How a Family Trust May Be Able To Help Preserve Your Wealth</li><li>A U.S. “birthright” claim worth trillions - activated quietly</li><li>Executive Order 14330: Trump’s Biggest Yet</li><li>“Fed Proof” Your Bank Account with THESE 4 Simple Steps</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNOQw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Centene Right Now?</h2><p>Before you consider Centene, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Centene wasn't on the list.</p><p>While Centene currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Ashton Thomas Securities LLC reduced its stake in Centene Corporation (NYSE:CNC) by 74.2% in Q3, now holding 14,822 shares valued at $529,000. Other investors, including Kera Capital Partners and Financial Network Wealth Advisors, also adjusted their positions. Centene's stock opened at $46.15, with a market cap of $22.68 billion and a P/E ratio of -4.26. The company reported $0.50 EPS for the last quarter, exceeding estimates, with revenue up 18.2% year-over-year. Analysts have mixed ratings, with an average target price of $40.38.</p>

Ashton Thomas Securities LLC Reduces Stock Position in Centene Corporation $CNC